Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Infectious Disease - Page 40

Infectious Disease

CDC Advisory Committee on Immunization Practices recommended vaccination with Moderna’s COVID-19 vaccine
Biotechnology | CDC | COVID-19 | Infectious Disease | Vaccine

CDC Advisory Committee on Immunization Practices recommended vaccination with Moderna’s COVID-19 vaccine

On Dec. 18, 2020, Moderna announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on…

Read More CDC Advisory Committee on Immunization Practices recommended vaccination with Moderna’s COVID-19 vaccineContinue

National Research Council of Canada supported development of 4 COVID-19 therapeutic candidates
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

National Research Council of Canada supported development of 4 COVID-19 therapeutic candidates

On Dec. 18, 2020, the National Research Council of Canada (NRC) announced it was providing advisory services and…

Read More National Research Council of Canada supported development of 4 COVID-19 therapeutic candidatesContinue

Novavax announced agreement with government of New Zealand for 107 million doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax announced agreement with government of New Zealand for 107 million doses of COVID-19 vaccine

On Dec. 16, 2020, Novavax announced an Advance Purchase Agreement with the government of New Zealand for the…

Read More Novavax announced agreement with government of New Zealand for 107 million doses of COVID-19 vaccineContinue

Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity
Biotechnology | COVID-19 | Infectious Disease | Organ Transplant | Pharmaceutical | Therapeutics

Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity

On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…

Read More Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacityContinue

INOVIO to develop DNA-encoded monoclonal antibody (dMAb) candidates to treat COVID-19
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

INOVIO to develop DNA-encoded monoclonal antibody (dMAb) candidates to treat COVID-19

On Dec. 15, 2020, Inovio Pharma announced the company and a team of scientists from The Wistar Institute,…

Read More INOVIO to develop DNA-encoded monoclonal antibody (dMAb) candidates to treat COVID-19Continue

U.S. Dept of Veterans Affairs began COVID-19 vaccinations
COVID-19 | Infectious Disease | Vaccine

U.S. Dept of Veterans Affairs began COVID-19 vaccinations

On Dec. 14, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that the New Orleans and Bedford,…

Read More U.S. Dept of Veterans Affairs began COVID-19 vaccinationsContinue

Anixa Biosciences Covid-19 therapy demonstrated comparable potency to remdesivir in pre-clinical testing
Biotechnology | COVID-19 | Infectious Disease | Therapeutics | Vaccine

Anixa Biosciences Covid-19 therapy demonstrated comparable potency to remdesivir in pre-clinical testing

On Dec. 14, 2020, Anixa Biosciences announced that it and partner OntoChem GmbH had verified that one of…

Read More Anixa Biosciences Covid-19 therapy demonstrated comparable potency to remdesivir in pre-clinical testingContinue

Moderna confirmed supply agreement to supply Singapore with mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna confirmed supply agreement to supply Singapore with mRNA vaccine against COVID-19

On Dec. 14, 2020, Moderna confirmed that the Company had concluded an agreement with the Ministry of Health…

Read More Moderna confirmed supply agreement to supply Singapore with mRNA vaccine against COVID-19Continue

AI test ruled out a COVID-19 diagnosis within one hour in Emergency Departments
Artificial Intelligence | Biology | COVID-19 | Infectious Disease | Therapeutics

AI test ruled out a COVID-19 diagnosis within one hour in Emergency Departments

On Dev. 11, 2020, the University of Oxford reported that an Artificial Intelligence test had been shown to…

Read More AI test ruled out a COVID-19 diagnosis within one hour in Emergency DepartmentsContinue

U.S. Government exercised 1st option for additional 100 million doses of Moderna’s COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

U.S. Government exercised 1st option for additional 100 million doses of Moderna’s COVID-19 vaccine

On Dec. 11, 2020, Moderna announced that the U.S. government has exercised its option to purchase an additional…

Read More U.S. Government exercised 1st option for additional 100 million doses of Moderna’s COVID-19 vaccineContinue

Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Biotechnology | FDA | Infectious Disease | Vaccine

Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials

On Dec. 10, 2020, Roche announced a partnership with Moderna to utilise the Elecsys Anti-SARS-CoV-2 S antibody test…

Read More Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trialsContinue

ImmunityBio’s hAd5 T-Cell COVID-19 vaccine candidate showed complete protection of airways
Biotechnology | COVID-19 | Infectious Disease | Vaccine

ImmunityBio’s hAd5 T-Cell COVID-19 vaccine candidate showed complete protection of airways

On Dec. 10, 2020, ImmunityBio announced its COVID-19 vaccine candidate protected nasal and lung airways of non-human primates…

Read More ImmunityBio’s hAd5 T-Cell COVID-19 vaccine candidate showed complete protection of airwaysContinue

Moderna announced first participants dosed in phase 2/3 study of COVID-19 vaccine candidate in adolescents
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced first participants dosed in phase 2/3 study of COVID-19 vaccine candidate in adolescents

On Dec. 10, 2020, Moderna announced that the first adolescent participants had been dosed in the Phase 2/3…

Read More Moderna announced first participants dosed in phase 2/3 study of COVID-19 vaccine candidate in adolescentsContinue

Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Biotechnology | FDA | Infectious Disease | Vaccine

Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials

On Dec. 9, 2020, Roche announced a partnership with Moderna to utilise the Elecsys Anti-SARS-CoV-2 S antibody test…

Read More Roche partnered with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trialsContinue

Switzerland exercised increased option for 7.5 million doses of mRNA vaccine against COVID-19 (mRNA-1273)
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Switzerland exercised increased option for 7.5 million doses of mRNA vaccine against COVID-19 (mRNA-1273)

On Dec. 8, 2020, Moderna announced the Swiss Federal Government had increased its confirmed order commitment from 4.5…

Read More Switzerland exercised increased option for 7.5 million doses of mRNA vaccine against COVID-19 (mRNA-1273)Continue

INOVIO dosed first subject in phase 2 segment of INNOVATE phase 2/3 trial for INO-4800 to prevent COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO dosed first subject in phase 2 segment of INNOVATE phase 2/3 trial for INO-4800 to prevent COVID-19

On Dec. 7, 2020, Inovio Pharmaceuticals announced it had dosed its first subject in a Phase 2 clinical…

Read More INOVIO dosed first subject in phase 2 segment of INNOVATE phase 2/3 trial for INO-4800 to prevent COVID-19Continue

Mount Sinai researchers advanced universal influenza virus vaccine
Biotechnology | Infectious Disease | Influenza | Vaccine

Mount Sinai researchers advanced universal influenza virus vaccine

On Dec. 7, 2020, an universal influenza virus vaccine, which produces antibodies that target the part of the…

Read More Mount Sinai researchers advanced universal influenza virus vaccineContinue

Canada exercised increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Canada exercised increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19

On Dec. 7, 2020, Moderna announced that the Canadian Government had increased its confirmed order commitment by 20…

Read More Canada exercised increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19Continue

High-dose influenza vaccine showed no additional benefit for heart disease patients
Biotechnology | Disease | Infectious Disease | Influenza | Therapeutics | Vaccine

High-dose influenza vaccine showed no additional benefit for heart disease patients

On Dec. 4, 2020, it was reported in JAMA that high-dose influenza (commonly known as flu) vaccines are…

Read More High-dose influenza vaccine showed no additional benefit for heart disease patientsContinue

FDA authorized first COVID-19 and flu combination test for use with home-collected samples
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza

FDA authorized first COVID-19 and flu combination test for use with home-collected samples

On Dec. 4, 2020, the U.S. Food and Drug Administration (FDA) authorized the first diagnostic test for at home collection…

Read More FDA authorized first COVID-19 and flu combination test for use with home-collected samplesContinue

Moderna updated on clinical development and production of Its COVID-19 vaccine candidate
Biotechnology | COVID-19 | Infectious Disease | NIH | Vaccine

Moderna updated on clinical development and production of Its COVID-19 vaccine candidate

On Dec. 3, 2020, Moderna announced in a letter to the editor published in the New England Journal…

Read More Moderna updated on clinical development and production of Its COVID-19 vaccine candidateContinue

INOVIO expanded global manufacturing consortium for COVID-19 vaccine candidate with Kaneka Eurogentec
Biotechnology | COVID-19 | Infectious Disease | Vaccine

INOVIO expanded global manufacturing consortium for COVID-19 vaccine candidate with Kaneka Eurogentec

On Dec. 3, 2020, Inovio Pharmaceuticals announced the execution of an agreement with Kaneka Eurogentec an affiliate of…

Read More INOVIO expanded global manufacturing consortium for COVID-19 vaccine candidate with Kaneka EurogentecContinue

University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific Impact
Biotechnology | Diagnostics | Disease | Infectious Disease | Medicine | Non-Profit Research | Therapeutics

University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific Impact

On Dec. 2, 2020, the University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific…

Read More University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific ImpactContinue

Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidate
Biotechnology | Clinical Research | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine

Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidate

On Nov. 30, 2020, Moderna announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273…

Read More Moderna announced primary efficacy analysis in phase 3 COVE study for COVID-19 vaccine candidateContinue

Novavax announced COVID-19 vaccine clinical development progress
Biotechnology | Infectious Disease | Vaccine

Novavax announced COVID-19 vaccine clinical development progress

On Nov. 30, 2020, Novavax announced that two of the three planned late-stage efficacy trials for NVX-CoV2373 sponsored…

Read More Novavax announced COVID-19 vaccine clinical development progressContinue

Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccine

On Nov. 29, 2020, Moderna announced a supply agreement with the United Kingdom (UK) government for an additional…

Read More Moderna amended supply agreement with UK Government for 2 million doses of mRNA COVID-19 vaccineContinue

Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccine

On Nov. 25, 2020, Moderna announced that the European Commission (EC) has approved an agreement to secure 80…

Read More Moderna announced EC approval of purchase agreement for 80 million doses of mRNA COVID-19 vaccineContinue

BioNTech and InstaDeep announce AI Innovation Lab to develop novel immunotherapies
Artificial Intelligence | Biotechnology | Infectious Disease | Therapeutics

BioNTech and InstaDeep announce AI Innovation Lab to develop novel immunotherapies

On Nov. 25, 2020, BioNTech and InstaDeep announced a multi-year strategic collaboration aimed at applying the latest advances…

Read More BioNTech and InstaDeep announce AI Innovation Lab to develop novel immunotherapiesContinue

Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected person
Biotechnology | Infectious Disease | Influenza | Vaccine

Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected person

On Nov. 24, 2020, Roche announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…

Read More Roche announced FDA approval of Xofluza for prevention of influenza following contact with infected personContinue

AI detected COVID-19 on chest X-rays faster and with more accuracy than radiologists
Biotechnology | COVID-19 | Infectious Disease | Oncology | Radiology | Therapeutics

AI detected COVID-19 on chest X-rays faster and with more accuracy than radiologists

On Nov. 24, 2020, Northwestern University researchers announced they had developed a new artificial intelligence (A.I.) platform that…

Read More AI detected COVID-19 on chest X-rays faster and with more accuracy than radiologistsContinue

Page navigation

Previous PagePrevious 1 … 38 39 40 41 42 … 70 Next PageNext
  • Categories
  • Timeline
  • Aesthetics
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Quantum
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search